Masthead.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. fmi, doi. 10.1002/clc.4960241301
- Publication type:
- Article
Works matching IS 01609289 AND DT 2001 AND VI 24 AND IP S1
Results: 7
1
2
The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS study.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. 12, doi. 10.1002/clc.4960241305
- By:
- Publication type:
- Article
3
Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. 8, doi. 10.1002/clc.4960241304
- By:
- Publication type:
- Article
4
Improving outcomes in acute coronary syndromes-The FRISCII trial.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. 3, doi. 10.1002/clc.4960241303
- By:
- Publication type:
- Article
5
Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. 20, doi. 10.1002/clc.4960241307
- By:
- Publication type:
- Article
6
Acute coronary care and beyond: The expanding role of low-molecular-weight heparin.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. 1, doi. 10.1002/clc.4960241302
- By:
- Publication type:
- Article
7
Atrial fibrillation: Is there a role for low-molecular-weight heparin?
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S1, p. 15, doi. 10.1002/clc.4960241306
- By:
- Publication type:
- Article